Budget Express 2026

co-presented by

ASSOCIATE SPONSORS

Jubilant Draximage Montreal Canada

Jump to

Jubilant Life soars over 12% ; mcap rises by Rs 1,225 cr

Shares of Jubilant Life Sciences today ended with over 12 percent gains, adding Rs 1,224.82 crore to its market valuation, after the company said its subsidiary has signed long-term contracts in the US for supply of some of its diagnostic and therapeutic products.
Jubilant Life Sciences arm gets US FDA nod for coronary drug

Jubilant Life Sciences today said its wholly-owned subsidiary has received approval from the US health regulator for RUBY-FILL -- Rubidium 82 generator and elution system -- used in diagnosis of coronary artery disease in the US market.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347